NCT06083454 2026-03-13
Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)
University of Iowa
Phase 1 Terminated
Clinical Trials
9 trialsNCT02887521 2025-02-03
Pulmonary Rehabilitation Before Lung Cancer Resection
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT00687986 2022-03-17
ROSEL
Amsterdam UMC, location VUmc
Phase 3 Terminated
NCT00840749 2020-07-14
STARS
Accuray Incorporated
Phase NA Terminated
NCT00924209 2018-11-30
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT02326285 2018-01-23
NeoIntercal
AIO-Studien-gGmbH
Phase 2/3 Terminated
NCT00281827 2017-12-28
Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00316134 2011-11-08
Multiple Biomarkers in Undiagnosed Pleural Effusion
Fujirebio Diagnostics, Inc.
Terminated
NCT00098917 2008-01-28
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Terminated